These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 7426837

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Intrinsic sympathomimetic activity of labetalol.
    Tadepalli AS, Novak PJ.
    J Cardiovasc Pharmacol; 1986; 8(1):44-50. PubMed ID: 2419691
    [Abstract] [Full Text] [Related]

  • 26. Comparison of labetalol, clonidine and diazoxide intravenously administered in severe hypertension.
    Yeung CK, Thomas GW, Whitworth JA, Kincaid-Smith P.
    Med J Aust; 1979 Nov 03; 2(9):499-500. PubMed ID: 522807
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A study of the labetalol-induced changes in conductivity and refractoriness of the dog heart in situ.
    Amlie JP.
    Cardiovasc Res; 1978 Nov 03; 12(11):646-52. PubMed ID: 750077
    [Abstract] [Full Text] [Related]

  • 29. Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension.
    Bahlmann J, Brod J, Hubrich W, Cachovan M, Pretschner P.
    Br J Clin Pharmacol; 1979 Nov 03; 8(Suppl 2):113S-117S. PubMed ID: 526390
    [Abstract] [Full Text] [Related]

  • 30. The use of labetalol as a moderate hypotensive agent in otological operations--plasma concentrations after intravenous administration.
    Kanto J, Pakkanen A, Allonen H, Kleimola T, Mäntylä R.
    Int J Clin Pharmacol Ther Toxicol; 1980 Nov 03; 18(5):191-4. PubMed ID: 7390669
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
    Koch G.
    Br J Clin Pharmacol; 1976 Aug 03; 3(4 Suppl 3):725-8. PubMed ID: 10950
    [Abstract] [Full Text] [Related]

  • 33. Comparison of labetalol with other anti-hypertensive drugs.
    Prichard BN, Richards DA.
    Br J Clin Pharmacol; 1982 Jun 03; 13(1 Suppl):41S-47S. PubMed ID: 6124265
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The effect of clonidine on venous haemodynamics in cats and dogs.
    Bentley GA, Cullen LK, Reynoldson JA, Widdop RE.
    Br J Pharmacol; 1986 May 03; 88(1):161-71. PubMed ID: 3708214
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I, Lorrain J, Di Paola ED, Lhoste F, Payen B, Dennis T, Scatton B.
    J Pharmacol Exp Ther; 1985 Dec 03; 235(3):798-809. PubMed ID: 2934543
    [Abstract] [Full Text] [Related]

  • 39. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
    Lammintausta R, Koulu M, Allonen H.
    Int J Clin Pharmacol Biopharm; 1979 Jun 03; 17(6):240-43. PubMed ID: 38214
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.